Brief: OptimizeRx Corp Files For Non Timely Annual Report
March 28 (Reuters) - OPTIMIZERx Corp OPRX.O :
* OPTIMIZERX CORP - FILES FOR NON TIMELY 10-K WITH U.S. SEC
* OPTIMIZERX - EXPERIENCED DELAYS IN COMPILING AND
FINALIZING
ACCOUNTING DOCUMENTATION ASSOCIATED WITH ITS OCTOBER 2023
ACQUISITION OF HEALTHY OFFERS
* OPTIMIZERX - SAW DELAYS IN PERFORMING REMEDIATION OF
DISCLOSED
MATERIAL WEAKNESS IN TESTING, VALIDATION OF INTERNAL PROCESSES
WITH 3RD-PARTY VENDORS
Source text for Eikon: ID:n0001213900-24-026908
Further company coverage: OPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptimizeRx
See all newsBrief: Optimizerx Announces Finance Leadership Appointments To Support The Next Phase Of Growth
OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary
OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook
OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview
Brief: Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing